(R)-Brivanib alaninate-d4

(R)-Brivanib alaninate-d4

• UNSPSC Description: (R)-Brivanib alaninate-d4 is the deuterium-labeled Brivanib (alaninate) (HY-10336). Brivanib alaninate (BMS-582664) is an ATP-competitive inhibitor against VEGFR2 with an IC50 of 25 nM; has moderate potency against VEGFR-1 and FGFR-1, but more than 240-fold against PDGFRβ[1].
• Target Antigen: Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Others
• Field of Research: Others
• Solubility: 10 mM in DMSO
• Smiles: CC1=CC2=C(N1)C=CC(OC3=NC=NN4C3=C(C(OC[C@H](OC(C([2H])(C([2H])([2H])[2H])N)=O)C)=C4)C)=C2F
• Molecular Weight: 445.48
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported